Zobrazeno 1 - 10
of 60
pro vyhledávání: '"K D, Watenpaugh"'
Autor:
Martin R. Deibel, Constance G Chidester, Cindy L Wolfe, K. D. Watenpaugh, Anthony W. Yem, Ross Reynolds
Publikováno v:
Journal of Molecular Biology. 293:559-568
Cdc25B is a dual specificity phosphatase involved in the control of cyclin-dependent kinases and the progression of cells through the cell cycle. A series of minimal domain Cdc25B constructs maintaining catalytic activity have been expressed. The str
Publikováno v:
Biochemical and Biophysical Research Communications. 259:420-428
Tau protein kinase II (TPKII) is a heterodimer comprising a catalytic cyclin-dependent kinase subunit (Cdk5) and a regulatory protein called neuronal Cdk5 activator (Nck5a). TPKII is somewhat reminiscent, therefore, of the Cdk2-cyclin complex importa
Autor:
Lester A. Dolak, Johnson Paul D, Chong Kt, Harvey Irving Skulnick, Paul K. Tomich, Michael John Bohanon, Strohbach Joseph Walter, Suvit Thaisrivongs, Steve Turner, K. D. Watenpaugh, M.‐M. Horng, M.N. Janakiraman, R. R. Hinshaw, Paul A. Aristoff, J. C. Lynn, Eric P. Seest, Tommasi Ruben A
Publikováno v:
Journal of Medicinal Chemistry. 41:3467-3476
A broad screening program previously identified phenprocoumon (1) as a small molecule template for inhibition of HIV protease. Subsequent modification of this lead through iterative cycles of structure-based design led to the activity enhancements of
Autor:
Suvit Thaisrivongs, Tommasi Ruben A, Chong Kt, K. D. Watenpaugh, Paul K. Tomich, Strohbach Joseph Walter, Steve R. Turner, M.N. Janakiraman
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 8:1237-1242
Potent, non-peptidic, dihydropyrone sulfonamide HIV protease inhibitors have been previously described. Crystallographic analysis of dihydropyrone sulfonamide inhibitor/HIV protease complexes suggested incorporation of a second, C2 symmetry-related s
Autor:
J. C. Lynn, Tommasi Ruben A, Johnson Paul D, Strohbach Joseph Walter, R. R. Hinshaw, M.N. Janakiraman, Chong Kt, Turner, Paul A. Aristoff, Morge Rr, Howe Wj, Tomich Pk, Donna L. Romero, M.‐M. Horng, Barry C. Finzel, Carolyn Biles, K. D. Watenpaugh, Suvit Thaisrivongs
Publikováno v:
Journal of Medicinal Chemistry. 39:4630-4642
From a broad screening program, the 4-hydroxycoumarin phenprocoumon (I) was previously identified as a lead template with HIV protease inhibitory activity. The crystal structure of phenprocoumon/HIV protease complex initiated a structure-based design
Autor:
S, Thaisrivongs, M N, Janakiraman, K T, Chong, P K, Tomich, L A, Dolak, S R, Turner, J W, Strohbach, J C, Lynn, M M, Horng, R R, Hinshaw, K D, Watenpaugh
Publikováno v:
Journal of Medicinal Chemistry. 39:2400-2410
The low oral bioavailability and rapid biliary excretion of peptide-derived HIV protease inhibitors have limited their utility as potential therapeutic agents. Our broad screening program to discover non-peptidic HIV protease inhibitors previously id
Autor:
L. F. Ten Eyck, K. D. Watenpaugh
Publikováno v:
International Tables for Crystallography ISBN: 9780470660782
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8df30c5795d12372a23ebb9cc396195e
https://doi.org/10.1107/97809553602060000855
https://doi.org/10.1107/97809553602060000855
Autor:
Turner, Chong Kt, K. D. Watenpaugh, Howe Wj, Tomich Pk, Yang Cp, McGrath Jp, Michael John Bohanon, Strohbach Joseph Walter, Suvit Thaisrivongs
Publikováno v:
Journal of Medicinal Chemistry. 37:3200-3204
Autor:
A. M. Mulichak, A G Tomasselli, Suvit Thaisrivongs, Robert L. Heinrikson, K. A. Curry, J. O. Hui, Che-Shen C. Tomich, K. D. Watenpaugh, Tomi K. Sawyer
Publikováno v:
Journal of Biological Chemistry. 268:13103-13109
The crystal structure of human immunodeficiency virus (HIV) type 2 protease has been determined in complexes with peptidic inhibitors Noa-His-Cha psi [CH(OH)CH(OH)]Val-Ile-Amp (U75875) and Qnc-Asn-Cha psi [CH(OH)CH2]Val-Npt(U92163) (where Noa is naph
Publikováno v:
Acta Crystallographica Section D Biological Crystallography. 49:100-106
Xtal3.2, a crystallographic software package, is an international development project involving about 40 researchers over a full spectrum of crystallographic interests. This development has been supported by many national and international agencies a